Expression and mutation status of candidate kinases in multiple myeloma.

作者信息

Claudio J O, Zhan F, Zhuang L, Khaja R, Zhu Y X, Sivananthan K, Trudel S, Masih-Khan E, Fonseca R, Bergsagel P L, Scherer S W, Shaughnessy J, Stewart A K

出版信息

Leukemia. 2007 May;21(5):1124-7. doi: 10.1038/sj.leu.2404612. Epub 2007 Mar 8.

DOI:10.1038/sj.leu.2404612

PMID:17344920

Abstract

摘要

相似文献

Expression and mutation status of candidate kinases in multiple myeloma.

Leukemia. 2007 May;21(5):1124-7. doi: 10.1038/sj.leu.2404612. Epub 2007 Mar 8.

Using digital polymerase chain reaction to detect minimal residual disease in myeloma by identifying FGFR3 up-regulation.

Leuk Lymphoma. 2015;56(9):2714-6. doi: 10.3109/10428194.2014.1003061. Epub 2015 Feb 17.

The fibroblast growth factors in multiple myeloma.

Leukemia. 2006 Jun;20(6):1165-8. doi: 10.1038/sj.leu.2404202.

Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations.

Oncogene. 2001 Jun 14;20(27):3553-62. doi: 10.1038/sj.onc.1204465.

Novel mutation and RNA splice variant of fibroblast growth factor receptor 3 in multiple myeloma patients at diagnosis.

Haematologica. 2002 Oct;87(10):1036-40.

Very low mutation frequency of exons 5-9 in the CARD11 gene from 186 adult acute leukemia and 31 multiple myeloma samples.

Leuk Res. 2011 May;35(5):e46-7. doi: 10.1016/j.leukres.2010.11.017. Epub 2010 Dec 19.

Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers.

Hum Mutat. 2006 Oct;27(10):1060-1. doi: 10.1002/humu.9452.

A novel mutation involving the carboxy terminal region of the FGFR3 gene in a multiple myeloma patient with t(4;14).

Leukemia. 2002 Jun;16(6):1201-2. doi: 10.1038/sj.leu.2402502.

FGFR3 amplification in the absence of IGH@-FGFR3 fusion t(4;14) in myeloma.

Cancer Genet Cytogenet. 2009 Nov;195(1):92-3. doi: 10.1016/j.cancergencyto.2009.06.018.

[Case report; A case of multiple myeloma which cells gained multiple gene and chromosome aberrations and changed their morphology to plasmablastoid and lymphoblastoid during less than two years course].

Nihon Naika Gakkai Zasshi. 2012 Nov 10;101(11):3236-8. doi: 10.2169/naika.101.3236.

引用本文的文献

The WNT receptor ROR2 drives the interaction of multiple myeloma cells with the microenvironment through AKT activation.

Leukemia. 2020 Jan;34(1):257-270. doi: 10.1038/s41375-019-0486-9. Epub 2019 May 31.

EphB4: A promising target for upper aerodigestive malignancies.

Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):128-137. doi: 10.1016/j.bbcan.2018.01.003. Epub 2018 Jan 31.

Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung Cancer.

Sci Rep. 2015 Jun 15;5:10641. doi: 10.1038/srep10641.

Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers.

Apoptosis. 2013 Dec;18(12):1447-68. doi: 10.1007/s10495-013-0886-7.

Resequencing analysis of the candidate tyrosine kinase and RAS pathway gene families in multiple myeloma.

Cancer Genet. 2012 Sep;205(9):474-8. doi: 10.1016/j.cancergen.2012.06.007.

Promises and challenges of MicroRNA-based treatment of multiple myeloma.

Curr Cancer Drug Targets. 2012 Sep;12(7):838-46. doi: 10.2174/156800912802429355.

Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion in glioblastoma multiforme cells.

Oncotarget. 2011 Nov;2(11):833-49. doi: 10.18632/oncotarget.346.

Monitoring a nuclear factor-κB signature of drug resistance in multiple myeloma.

Mol Cell Proteomics. 2011 Nov;10(11):M110.005520. doi: 10.1074/mcp.M110.005520. Epub 2011 Aug 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验